1422-76-0Relevant articles and documents
Sandmeyer reactions. Part 7.1 An investigation into the reduction steps of Sandmeyer hydroxylation and chlorination reactions
Hanson, Peter,Jones, Jason R.,Taylor, Alec B.,Walton, Paul H.,Timms, Allan W.
, p. 1135 - 1150 (2002)
For Sandmeyer hydroxylation and chlorination in aqueous solution, the reduction steps have been investigated by means of correlation analyses of the effects of diazonium ion substitution on the rates of reduction. For simple hydroxylation, a change of behaviour between diazonium ions substituted by electron donor groups and those substituted by electron acceptor groups is interpreted as a change within an inner-sphere process from rate-determining electron transfer to rate-determining association of the reactants. By contrast, for citrate-promoted hydroxylation, a similar change in behaviour may be interpreted as a change between inner- and outer-sphere electron transfers. For chlorination, there is no mechanistic variation within the range of substituents examined but the pattern of behaviour is consistent with an inner-sphere mechanism. The various patterns of behaviour are rationalised in terms of the effects of diazonium ion substitution and catalyst ligation on the reduction potentials and self-exchange rates of the various reacting redox couples. Comparative correlation analyses of reductions and other electrophilic reactions of diazonium ions are used to support the arguments advanced in respect of Sandmeyer reduction steps. It is suggested that the Cu1 reductants react via a nucleophilic bridging ligand at the diazonium Nβ to give transient Z-adducts which are the precursor complexes and that activation for electron transfer involves rotation about the N-N bond.
One-pot fluoro-de-diazoniation of anilines in organic medium
Garel, Laurent,Saint-Jalmes, Laurent
, p. 5705 - 5708 (2006)
Treatment of anilines with tert-butyl nitrite in the presence of boron trifluoride in ortho-dichlorobenzene leads to in situ fluoro-de-diazoniation and affords the corresponding fluoroaromatics with fair yields. This process, conducted in organic medium without Broensted acids, does not require isolation of hazardous diazonium salts and reduces the amounts of wastes. The results of the first screening are given.
Aqueous and Visible-Light-Promoted C-H (Hetero)arylation of Uracil Derivatives with Diazoniums
Liu, An-Di,Wang, Zhao-Li,Liu, Li,Cheng, Liang
, p. 16434 - 16447 (2021/11/16)
Direct C5 (hetero)arylation of uracil and uridine substrates with (hetero)aryl diazonium salts under photoredox catalysis with blue light was reported. The coupling proceeds efficiently with diazonium salts and heterocycles in good functional group tolerance at room temperature in aqueous solution without transition-metal components. A plausible radical mechanism has been proposed.
Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)
Pan, Shulei,Zhou, Yangli,Wang, Qiusheng,Wang, Yanlin,Tian, Chenyu,Wang, Tianqi,Huang, Luyi,Nan, Jinshan,Li, Linli,Yang, Shengyong
, (2020/09/01)
Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO), which mediate kynurenine pathway of tryptophan degradation, have emerged as potential new targets in immunotherapy for treatment of cancer because of their critical role in immunosuppression in the tumor microenvironment. In this investigation, we report the structural optimization and structure-activity relationship studies of 1-phenyl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as a new class of IDO1/TDO dual inhibitors. Among all the obtained dual inhibitors, 1-(3-chloro-4-fluorophenyl)-6-fluoro-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione (38) displayed the most potent IDO1 and TDO inhibitory activities with IC50 (half-maximal inhibitory concentration) values of 5 nM for IDO1 and 4 nM for TDO. It turned out that compound 38 was not a PAINS compound. Compound 38 could efficiently inhibit the biofunction of IDO1 and TDO in intact cells. In LL2 (Lewis lung cancer) and Hepa1-6 (hepatic carcinoma) allograft mouse models, this compound also showed considerable in vivo anti-tumor activity and no obvious toxicity was observed. Therefore, 38 could be a good lead compound for cancer immunotherapy and deserving further investigation.
